Article Impact Level: HIGH Data Quality: STRONG Summary of Nature Genetics https://doi.org/10.1038/s41588-026-02633-8 Dr. Dan Sarni et al.
Points
- An international study involving 76 researchers across seven countries identified a rare accelerated aging condition named Heyn–Sproul–Jackson syndrome.
- Genetic analysis revealed the syndrome is caused by DNMT3A gain-of-function mutations that rapidly replicate normal age-related accumulations of DNA methylation marks.
- Region-specific hypermethylation at lineage-specific genes caused widespread adult stem cell dysfunction, which severely compromised normal tissue renewal and regenerative capacity.
- Human patients presented with early-onset senescence pathologies including decreased blood cell production, heightened susceptibility to infection, osteoporosis, and hair loss.
- Corresponding mouse models demonstrated that accelerated DNA methylation alters cell metabolism, directly inducing pathologies equivalent to clinical diabetes and high cholesterol.
Summary
This study evaluated the pathophysiology of an epigenetically driven accelerated aging condition known as Heyn–Sproul–Jackson syndrome (HESJAS). While DNA methylation (DNAme) marks accumulate predictably over time to form a biological clock, establishing whether these alterations are correlative or causal to human tissue degeneration has presented long-standing mechanistic challenges. The international research collaboration sought to analyze how specific gain-of-function mutations alter normal DNA methylation rates and directly drive downstream clinical pathologies.
Using genetic mapping and mouse models, the investigators determined that HESJAS is caused by DNMT3A gain-of-function mutations that rapidly recapitulate the age-related gains in DNAme seen in normal senescence. This accelerated hypermethylation causes multilineage adult stem cell dysfunction by targeting lineage-specific genes, thereby halting normal tissue repair and replication. The analysis included data compiled by 76 researchers tracking phenotypic presentations across seven countries. (Note: Specific confidence intervals and hazard ratios were not reported in the primary source text).
Phenotypic characterization in both human subjects and mouse models confirmed that this epigenetic clock drives a broad spectrum of early-onset, age-related diseases. Affected individuals exhibited decreased hematopoietic output leading to immune susceptibility, alongside premature osteoporosis, hair loss, and compromised tissue renewal. Concurrently, the hypermethylated murine models developed metabolic alterations directly associated with diabetes and elevated cholesterol. These findings establish a direct causal link between DNAme-mediated stem cell exhaustion and major bone, blood, and metabolic disorders, offering novel pathways for targeted rejuvenation therapies.
Link to the article: https://www.nature.com/articles/s41588-026-02633-8
References
Sarni, D., Neary, G., Carroll, P. L., Vink, C. S., Billard, C. V., Isobe, T., Weng, X., Portman, J. R., McCartney, D. L., Heyn, P., van ‘t Hof, R. J., Morrison, L. R., Martin, C.-A., Stok, C., Harley, M. E., Leitch, A., van den Ancker, M., Robertson, N., Kitto, L., … Jackson, A. P. (2026). A progeria syndrome links DNA hypermethylation to age-related pathology. Nature Genetics, 1–11. https://doi.org/10.1038/s41588-026-02633-8
